For the Inventor, By the Inventor

Enter assignee name

Hamilton, Bermuda

Abbott Biotechnology Ltd.

USPTO Granted Patents = 17

% Expired Patents = 52.9

CIPO Patents = 1

EPO Patents = 2

Trademarks = 2

Forward Citations = 1,771

Loading Chart...

Loading Chart...

33 inventors (with patents filed for the assignee):

Boris Labkovsky (8 out of 34 patents)

Zehra Kaymakcalan (8 out of 32 patents)

Jochen G Salfeld (8 out of 33 patents)

4. Michael White (8 out of 25 patents)

5. Paul Sakorafas (8 out of 18 patents)

6. Deborah J Allen (8 out of 13 patents)

7. John A Mankovich (8 out of 17 patents)

8. Andrew J Roberts (8 out of 12 patents)

9. David Schoenhaut (8 out of 14 patents)

10. Tristan J Vaughan (8 out of 33 patents)

11. Brian Timothy McGuinness (8 out of 24 patents)

12. Alison Jane Wilton (7 out of 20 patents)

13. Hendricus R J M Hoogenboom (7 out of 13 patents)

14. Joseph F Julian (4 out of 32 patents)

15. Min M Wan (2 out of 13 patents)

17 patents: Sort by Forward Citations

1. 8414894 - Human antibodies that bind human TNFα and methods of using same (2013-04-09),

2. 8372401 - Human antibodies that bind human TNFα (2013-02-12),

3. 8372400 - Methods of treating disorders using human antibodies that bind human TNFα (2013-02-12),

4. 8231876 - Purified antibody composition (2012-07-31),

5. 8216583 - Formulation of human antibodies for treating TNF-α associated disorders (2012-07-10),

6. 8206714 - Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa (2012-06-26),

7. 8197813 - Human antibodies that bind human TNFα (2012-06-12),

8. 8162887 - Automatic injection devices (2012-04-24),

9. 8034906 - Crystalline anti-hTNFalpha antibodies (2011-10-11),

10. 7938802 - Automatic injection devices (2011-05-10),

11. 7919264 - Methods and compositions for determining the efficacy of a treatment for ankylosing spondylitis using biomarkers (2011-04-05),

12. 7863426 - Antibody purification (2011-01-04),

13. D629509 - Automatic injection device (2010-12-21),

14. D622374 - Automatic injection device (2010-08-24),

15. 7588761 - Human antibodies that bind human TNFα (2009-09-15),

Abbott Biotechnology Ltd. is a leading biotechnology company that focuses on research, development, and commercialization of innovative medical solutions. With a strong emphasis on improving patient outcomes, our dedicated team of scientists and researchers work tirelessly to develop cutting-edge biotechnology products in various therapeutic areas. Our mission is to transform lives by delivering safe, effective, and affordable treatments. Visit our website to learn more about our products and the breakthrough advancements we are making in the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

17 Patents

#32 in Hamilton

#37 in Bermuda

#35,837 in the World

Hamilton, Bermuda

Abbott Biotechnology Ltd.

Forward Citations = 1,771

33 inventors:

Boris Labkovsky (8 out of 34 patents)

Zehra Kaymakcalan (8 out of 32 patents)

Jochen G Salfeld (8 out of 33 patents)

4. Michael White (8 out of 25 patents)

5. Paul Sakorafas (8 out of 18 patents)

Please report any incorrect information to [email protected]

Loading…